TrialJournal of gastroenterology2007

Aberrant methylation of p16 predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients.

Mayumi Mitsuno et al.PubMed ↗Publisher ↗

No numbers read from the abstract.